Emcure Pharmaceuticals Ltd. Financials: Quarterly Results
Revenue
2272.94
Cr.
PAT
251.37
Cr.
EBITDA
373.96
Cr.
Emcure Pharmaceuticals Ltd. Q2FY26 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 2269.82 | 2100.54 | 2116.25 | 1962.63 | 2001.98 |
| Total Income From Operations (Cr.) | 2269.82 | 2100.54 | 2116.25 | 1962.63 | 2001.98 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 373.96 | 321.01 | 310.02 | 261.70 | 319.63 |
| P/L Before Exceptional Items & Tax (Cr.) | 341.42 | 294.26 | 270.99 | 229.92 | 273.41 |
| P/L After Tax from Ordinary Activities (Cr.) | 251.37 | 214.79 | 197.24 | 156.09 | 201.55 |
| Net Profit/Loss For the Period (Cr.) | 251.37 | 214.79 | 197.24 | 156.09 | 201.55 |
| Basic EPS | 12.85 | 10.92 | 9.97 | 8.12 | 10.33 |
FAQs
Emcure Pharmaceuticals Ltd. announced its quarterly results for Q2 FY2026 on November 11, 2025.
In Q2 FY2026, Emcure Pharmaceuticals Ltd. are as follows:
Revenue: ₹2272.94 crore
Net Profit: ₹251.37 crore.
For Q2 FY2026, Emcure Pharmaceuticals Ltd. posted ₹2272.94 crore in revenue and ₹251.37 crore in net profit.
Past quarterly results for Emcure Pharmaceuticals Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.